Ubiquitin-conjugating enzyme E2 variant 1 pseudogene 3 (UBE2V1P3)

UBE2V1 pseudogene 3 (abbreviated UBE2V1P3) is one of several pseudogenes sharing sequence similarity with the UBE2V1 gene, which encodes a ubiquitin-conjugating enzyme E2 variant involved in key signaling pathways and cell cycle processes[5]. Pseudogenes like UBE2V1P3 are characterized by having sequence similarity to protein-coding genes but lack the ability to encode functional protein products. As such, they are not considered therapeutic targets and do not have established functional roles, disease associations, or drug interactions. Research and functional data on UBE2V1P3 are lacking and any associations should be ascribed instead to the parental UBE2V1 gene, not to this pseudogene[2][3][5]. Summary of key points: - UBE2V1P3 is a non-coding pseudogene and not a canonical therapeutic target. - No functional, drug interaction, or disease association data specific to UBE2V1P3. - All recognized biology, targeting, and disease roles exist for the main gene UBE2V1, not its pseudogenes[2][3][5].